Search

everythinglearnresearchcommunity

for

Search:↓

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Women with PCOS have altered brain structure and reduced cognitive performance.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Adult acne is more common in women, often linked to hormones, and can be harder to treat.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Reticulocyte hemoglobin content is the best indicator of iron deficiency causing hair loss in women.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Atorvastatin is less effective for women with Hashimoto's thyroiditis.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Women with PCOS are more likely to experience depressive symptoms.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

High ferritin levels might be linked to chronic hair loss.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Finasteride with oral contraceptive helps improve hair loss in premenopausal women.

Certain hormone treatments can improve acne and related conditions in women.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.